METHYL 5-BROMO-1H-INDOLE-6-CARBOXYLATE, 95.0%, 10g

4'-Methylsulfanyl-biphenyl-3-carbaldehyde, 1g

N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine hydrochloride, 95.0%, 5g

1,4-Dithiothréitol (DTT), 100 g

2-(2-((Dimethylamino)methyl)phenyl)acetic acid, 95%, 1g

4-Amino-1-N-Fmoc-piperidine hydrochloride, 97.0%, 5g

Phosphomolybdic acid hydrate, 500g

Hydroxyde de sodium, min 98%, pa, ISO, en pastilles, 10 kg, emballage plastique.

ethyl 2-(methylthio)-1,3-thiazole-4-carboxylate, 1g

1-((S)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanamido)cyclopropanecarboxamide, 98%, 25mg

Methyl 2-BOC-2-aza-spiro[3.3]heptane-6-carboxylate, 95.0%, 100mg

(4-Bromothiophen-3-yl)boronic acid, 95.0%, 10g

(R)-2-(tert-butoxycarbonyl)-5-(methylsulfonyl)isoindoline-1-carboxylic acid, 97%, 250mg